Showing results (11-20 of 255) with videos related to

Sort By:
Pageof 26
European Journal of Pharmacology|June 12, 2012
Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effectsMarigo Stathis, Claudio Pietra, Camilo Rojas, et al.
European Journal of Pharmacology|November 5, 2013
Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesisCamilo Rojas, Mithun Raje, Takashi Tsukamoto, et al.
Advances in Pharmacology (San Diego, Calif.)|July 21, 2024
Therapeutic resurgence of 6-diazo-5-oxo-l-norleucine (DON) through tissue-targeted prodrugsKateřina Novotná, Lukáš Tenora, Barbara S Slusher, et al.
Frontiers in Chemistry|June 7, 2022
Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future ProspectsMarcela Krečmerová, Pavel Majer, Rana Rais, et al.
Experimental Brain Research|June 28, 2014
Netupitant and palonosetron trigger NK1 receptor internalization in NG108-15 cellsAjit G Thomas, Marigo Stathis, Camilo Rojas, et al.
Analytical Biochemistry|November 5, 2002
Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assayCamilo Rojas, Scott T Frazier, Juliet Flanary, et al.
Analytical Biochemistry|January 14, 2015
Bioanalysis of 6-diazo-5-oxo-l-norleucine in plasma and brain by ultra-performance liquid chromatography mass spectrometryJesse Alt, Michelle C Potter, Camilo Rojas, et al.
ACS Chemical Neuroscience|October 14, 2020
Sowing the Seeds of Discovery: Tau-Propagation Models of Alzheimer's DiseaseBenjamin J Bell, Medhinee M Malvankar, Carolyn Tallon, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 5, 2013
Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disordersMichelle C Potter, Mariana Figuera-Losada, Camilo Rojas, et al.
Pageof 26